Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)

NCT02100228 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1500

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Apixaban
DRUG: Parenteral heparin and/or oral Vitamin K antagonist

Sponsor

Pfizer

Collaborators

[object Object]